Literature DB >> 19655287

The use of high-dose insulin-glucose euglycemia in beta-blocker overdose: a case report.

Colin Page1, L Peter Hacket, Geoffrey K Isbister.   

Abstract

The management of life-threatening beta-blocker toxicity and its associated low cardiac output state is clinically challenging. Previous case reports and case series describe the use of hyperinsulinemia/euglycemia therapy in mono-ingestions of calcium channel blockers and mixed ingestions, including calcium channel and beta-blockers. In this case report we describe the use of high-dose insulin (10 IU/kg per hour) in a case of massive metoprolol ingestion (5g) in which hypotension was unresponsive to conventional therapies. Although the metoprolol concentrations measured in plasma were approximately 100-200 times therapeutic concentrations, the pharmacokinetics appeared to be similar to therapeutic metoprolol dosing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655287      PMCID: PMC3550395          DOI: 10.1007/bf03161225

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  9 in total

Review 1.  Management of beta-adrenergic blocker and calcium channel antagonist toxicity.

Authors:  William Kerns
Journal:  Emerg Med Clin North Am       Date:  2007-05       Impact factor: 2.264

2.  Haemodynamic effects of low and high doses of insulin during beta receptor blockade in dogs.

Authors:  O Reikerås; P Gunnes; D Sørlie; R Ekroth; R Jorde; O D Mjøs
Journal:  Clin Physiol       Date:  1985-10

3.  Insulin improves survival in a canine model of acute beta-blocker toxicity.

Authors:  W Kerns; D Schroeder; C Williams; C Tomaszewski; R Raymond
Journal:  Ann Emerg Med       Date:  1997-06       Impact factor: 5.721

Review 4.  Recognition and management of poisoning with beta-adrenergic blocking agents.

Authors:  R S Weinstein
Journal:  Ann Emerg Med       Date:  1984-12       Impact factor: 5.721

5.  beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management.

Authors:  Paul M Wax; Andrew R Erdman; Peter A Chyka; Daniel C Keyes; E Martin Caravati; Lisa Booze; Gwenn Christianson; Alan Woolf; Kent R Olson; Anthony S Manoguerra; Elizabeth J Scharman; William G Troutman
Journal:  Clin Toxicol (Phila)       Date:  2005       Impact factor: 4.467

Review 6.  The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning.

Authors:  Bruno Mégarbane; Souheil Karyo; Frédéric J Baud
Journal:  Toxicol Rev       Date:  2004

7.  Relative toxicity of beta blockers in overdose.

Authors:  D M Reith; A H Dawson; D Epid; I M Whyte; N A Buckley; G P Sayer
Journal:  J Toxicol Clin Toxicol       Date:  1996

8.  Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity.

Authors:  Joel S Holger; Kristin M Engebretsen; Sandy J Fritzlar; Lane C Patten; Carson R Harris; Thomas J Flottemesch
Journal:  Clin Toxicol (Phila)       Date:  2007-05       Impact factor: 4.467

9.  Direct effect of high-dose insulin on the depressed heart after beta-blockade or ischemia.

Authors:  I Krukenkamp; D Sørlie; N Silverman; A Pridjian; S Levitsky
Journal:  Thorac Cardiovasc Surg       Date:  1986-10       Impact factor: 1.827

  9 in total
  3 in total

1.  Intravenous lipid emulsion does not augment blood pressure recovery in a rabbit model of metoprolol toxicity.

Authors:  Alexander Browne; Martyn Harvey; Grant Cave
Journal:  J Med Toxicol       Date:  2010-12

2.  Toxic bradycardias in the critically ill poisoned patient.

Authors:  Melissa L Givens
Journal:  Emerg Med Int       Date:  2012-04-01       Impact factor: 1.112

3.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.